22 January 2023 in Clinical Otolaryngology
20 September 2024 in The Laryngoscope
Objective: To study predictors of delayed presentation, diagnosis, and treatment of idiopathic sudden sensorineural hearing loss (ISSNHL).Study Design: Retrospective medical chart review and patient telephone survey.Setting: Tertiary medical center.Subjects and Methods: All patients who initially presented or referred with unilateral ISSNHL between 2016 and 2020 were included. Associations between epidemiological, demographic, and socioeconomic profiles and delays in presentation, diagnosis and treatment were studied.Results: A total of 518 patients were suitable for study inclusion. The total delay in the emergency department (ED) setup was a median (interquartile range, IQR) of 1 (0–1) day, 7 (6–12) days in a community otolaryngologist setup, and 15 (8–25) days in a general practitioner setup. Patients who presented to the ED first also had fewer diagnostic and treatment delays. Those who presented to a community otolaryngologist first had significantly longer presentation delay (5 [4–8] days p < 0.001) and significantly longer treatment delays (1 [1–3] days p < 0.001). Patients who presented to a general practitioner first had significantly longer presentation delays compared with ED presentation, and the longest diagnostic and treatment delays (3 [2–5], 8 [4–12] days, and 4 [2–7] days, p = < 0.01, p = <0.01, and p < 0.001, respectively). There was no association between socioeconomic status or demography and presentation, diagnostic, or treatment delays.Conclusion: Total delay in ISSNHL management is affected by the venue of the first medical encounter. General practitioners' level of awareness of the need for empiric steroidal treatment of ISSNHL without delay should be raised.Level of Evidence: 3 Laryngoscope, 135:889–893, 2025
27 September 2025 in World Journal of Otorhinolaryngology - Head and Neck Surgery
NNNarin Nard Carmel Neiderman
Narin Nard Carmel Neiderman
+1
Purpose: The rising prevalence of obesity introduces challenges in surgical contexts, including endoscopic sinus surgery (ESS) for chronic rhinosinusitis with nasal polyps (CRSwNP). However, the impact of obesity on ESS outcomes remains underexplored. This study aims to evaluate the association between obesity and surgical complexity, operative duration, postoperative quality of life (QOL), in patients with CRSwNP undergoing ESS.Methods: A retrospective analysis was conducted on 310 adult patients who underwent ESS for CRSwNP at a tertiary medical center between 2013 and 2023. Patients were categorized into two groups: Nonobese (BMI < 30 kg/m²) and obese (BMI ≥ 30 kg/m²). Outcomes assessed included operative time, postoperative complications, and QOL using the Sinonasal Outcome Test (SNOT‐22).Results: Of the 310 patients, 62 (20%) were obese. Obese patients had significantly higher preoperative Lund–Mackay scores (18.5 ± 4.7 vs. 16 ± 5.5, p = 0.036), longer operative durations (179 ± 61 vs. 162 ± 59 min, p = 0.034), and worse postoperative SNOT‐22 scores (38 ± 26 vs. 24 ± 22, p = 0.041) compared to nonobese patients. However, only six obese patients completed paired pre‐ and postoperative snot‐22 data. They were also more likely to require prolonged oral steroid use (> 3 months) (37% vs. 21%, p = 0.013) and biological treatments (21% vs. 8%, p = 0.01). No significant differences were observed in immediate postoperative complications or hospital stays.Conclusion: Obesity was not associated with increased surgical risk or delayed recovery following ESS for CRSwNP. However, obese patients had more severe disease and achieved less symptom improvement, highlighting the need for tailored postoperative care and adjunct therapies to optimize outcomes.
6 July 2026 in International Forum of Allergy & Rhinology
Key Points: The emotional burden of olfactory dysfunction bears distinct psychological profiles. Objective olfactory dysfunction findings do not reliably reflect patients' emotional burden. Olfactory‐related quality of life assessment may identify patient risk of emotional distress.
16 July 2026 in International Forum of Allergy & Rhinology
30 July 2026 in American Journal of Rhinology & Allergy
Background: Recurrent acute rhinosinusitis (RARS) is traditionally regarded as an episodic infectious disorder with complete mucosal recovery between attacks. However, histopathological evidence supporting this assumption is limited. Objective: To evaluate whether mucosal inflammatory and remodeling changes persist during the asymptomatic interval in patients with RARS compared with nonsinusitis surgical controls. Methods: In this prospective observational study (January 2023–December 2025), sinonasal mucosal specimens obtained during functional endoscopic sinus surgery were analyzed from adults with RARS and nonsinusitis surgical controls. Patients with chronic rhinosinusitis, active infection, or recent systemic corticosteroid use were excluded. Histopathological outcomes included neovascularization, submucosal fibrosis, inflammatory infiltration, and basement membrane thickness. Results: Twenty-four patients were included (17 RARS; 7 controls). Compared with controls, RARS specimens demonstrated higher neovascularization scores (median 2.0 vs 1.0; median difference, 1.0; 95% CI, 0.2-1.8; P = .034) and greater submucosal fibrosis (median 2.0 vs 1.0; median difference, 1.0; 95% CI, 0.1-1.9; P = .047). Inflammatory infiltration was numerically higher but did not reach statistical significance (median difference, 0.5; 95% CI, −0.1 to 1.1; P = .053); severe inflammation was observed only in RARS specimens (35% vs 0%). Basement membrane thickness did not differ between groups. Higher symptom burden (SNOT-22 ≥ 57.5) was associated with greater fibrosis ( P = .041). Conclusion: In this surgically treated cohort, RARS was associated with persistent mucosal neovascularization and fibrosis despite clinical quiescence. These findings suggest that RARS may involve ongoing interepisode tissue remodeling rather than a purely episodic process.